Delivery Order SPE2DB25D9312-SPE2DB25FWUWP
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $21,664.16 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS...
- The Defense Logistics Agency awarded a delivery order valued at $36,122.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a specific pharmaceutical fulfillment under DMS Pharmaceutical Group's broader contractual relationship with the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order for $11,136.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, with a period of performance through August 30, 2024. This award is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,132.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract carries an ultimate completion date of September 30, 2025, and was awarded on September 9, 2025, with no set-aside designation applied. DMS Pharmaceutical Group will perform the work at its Park Ridge facility, delivering...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on September 3, 2025, with completion targeted for September 4, 2025, does not utilize a set-aside designation. The award represents a discrete purchase of pharmaceutical products to support military healthcare operations, drawing from DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,238.39 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prolastin C 1,000 mg/20 mL vials. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a continuation of the company's role as a critical supplier within the federal pharmaceutical supply chain. The award...
- The Defense Logistics Agency awarded a $18,273.77 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 24, 2025, for the supply of Prolastin C 1,000 mg/20 ml vials. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $17,223.68, is for the delivery of 4566275343 - PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,483.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which covers the supply of a comprehensive range of pharmaceutical products including branded and generic prescription...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,122.99 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a discrete pharmaceutical supply delivery under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA. The award carries no set-aside...
- SPE2DB25D9312Indefinite Delivery Contract
- SPE2DB25D9312-SPE2DB25FWUWPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,289.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 12, 2025. The delivery order covers Prolastin C (1,000 mg/20 ml vials), a therapeutic pharmaceutical product, with an ultimate completion date of October 3, 2025. This award utilizes a firm fixed-price contract type with no set-aside designation, allowing DMS Pharmaceutical Group to compete on a competitive basis leveraging its established position in the federal pharmaceutical supply chain. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. The IDC, awarded under the SPE2DB program, enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. As a certified woman-owned small business registered in the System for Award Management (SAM) since 2001, DMS Pharmaceutical Group has demonstrated consistent capability in fulfilling pharmaceutical supply requirements for military and federal healthcare systems across diverse product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.3k | 9/12/25 |